Abstract
Get full access to this article
View all access options for this article.
References
1.
Nance
MA
,
Sanders
G
Characteristics of individuals with Huntington's disease in long-term care . Movement Disord , 1996 ; 11 :542 –548 .
2.
Moskowitz
CB
,
Marder
K
Palliative care for people with late-stage Huntington's disease . Neurol Clin , 2001 ; 9 :849 –865 .
3.
Lanska
DJ
,
Lavine
L
,
Lanska
MJ
,
Schoenberg
BS
Huntington's disease mortality in the United States . Neurology , 1988 ; 38 :769 .
4.
Myers
RH
,
Sax
DS
,
Koroshetz
WJ
,
Mastromauro
C
,
Cupples
LA
,
Kiely
DK
,
Pettengill
FK
,
Bird
ED
Factors associated with slow disease progression in Huntington's disease . Arch Neurol , 1991 ; 448 :800 –804 .
5.
Sorensen
SA
,
Fenger
K
Causes of death in patients with Huntington's disease and in unaffected first degree relatives . J Med Genet , 1992 ; 29 :911 –914 .
6.
Vamos
M
,
Hambridge
J
,
Edwards
M
,
Conaghan
J
The impact of Huntington's disease on family life . Psychosomatics , 2007 ; 48 :400 –404 .
7.
Folstein
SE
. Huntington's Disease: A Disorder of Families . Baltimore, MD : The Johns Hopkins University Press , 1989 .
8.Huntington Study Group . Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial . Neurology , 2006 ; 66 :366 –372 .
9.
Bonelli
RM
,
Wenning
GK
Pharmacological management of Huntington's disease: An evidence-based review . Curr Pharm Design , 2006 ; 12 :2701 –2720 .
10.
Paulsen
JS
,
Hoth
KF
,
Nehl
C
,
Stierman
L
Critical periods of suicide risk in Huntington's disease . Am J Psychiatry , 2005 ; 162 :725 –731 .
11.VistaCare Inc. Hospice Eligibility Flipchart: Huntington's Disease . www.vistacare.com/eligibility/flipchart. 2007 December 7.